STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1423 by analyst upside · 2026-09-05
SEPN
Septerna, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+47.5%
implied upside to consensus target
Current Price $36.75
Consensus Target $54.22
Bull Target $62.0
Bear Target $48.0
Analysts Covering 9
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
8
Hold
0
Sell
0
52-Week Low $13.67
52-Week High $51.1
YTD Return +31.3%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.53
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $99M
Profit Margin -24.5%
52-WEEK RANGE
52-Week Low $13.67
52-Week High $51.1
Current Price $36.75
Bear Target $48.0
Bull Target $62.0
● Now $36.75 ● Target $54.22
TRADING DATA
Avg Volume 444K
YTD Return +31.3%
Analyst Count 9
Consensus Buy
Upside to Target +47.5%
Last Updated 2026-09-05

ANALYST SUMMARY

Septerna, Inc. (SEPN) is currently trading at $36.75 with a Wall Street consensus price target of $54.22, implying potential upside of 47.5% over the next 12 months. 9 analysts currently cover SEPN, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $62.0, while the most cautious has a target of $48.0.

SEPN operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 31.3% year-to-date and is currently trading near the upper end of its 52-week range of $13.67 – $51.1.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SEPN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Overweight → Overweight 2026-08-19 43% win rate (7 calls)
Jones Trading - Reiterated
Buy → Buy 2026-08-13 57% win rate (14 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-08-12 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-08-12 31% win rate (48 calls)
Guggenheim - Reiterated
Buy → Buy 2026-08-11 62% win rate (8 calls)
Guggenheim - Reiterated
Buy → Buy 2026-07-01 62% win rate (8 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-07-01 31% win rate (48 calls)
Truist Securities - Reiterated
Buy → Buy 2026-07-01 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
67
out of 100
Coverage depth
18/30
Consensus clarity
22/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →